Chongqing Taiji Industry (Group) Co., Ltd.SSE: 600129

Announcement on Obtaining Drug Registration Certificate for Atomoxetine Hydrochloride Capsules

· Issued by Chongqing Taiji Industry (Group) Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

Chongqing Taiji Industry (Group) Co., Ltd. announced that its subsidiary, Southwest Pharmaceutical Co., Ltd., has received a drug registration certificate for Atomoxetine Hydrochloride Capsules from the National Medical Products Administration.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Obtaining Drug Registration Certificate for Atomoxetine Hydrochloride Capsules

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Chongqing Taiji Industry (Group) Co., Ltd. on 6ix

Earlier from Chongqing Taiji Industry (Group)

Later from Chongqing Taiji Industry (Group)

All Chongqing Taiji Industry (Group) news releases